• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗血小板药物还是双香豆素:哪种是闭塞性动脉疾病最有效的预防措施?

Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?

作者信息

Poliwoda H, Avenarius H J

出版信息

Int Angiol. 1986 Jul-Sep;5(3):169-80.

PMID:2435823
Abstract

Arterial thromboses lead to disturbances of vital function: myocardial infarction, ischemic cerebral infarction, disorders of peripheral blood flow, nephrosclerosis. Prophylaxis of thrombosis is still an unsolved problem, since diseases caused by thrombosis remain the first cause of death, at least in Western countries. After describing the pathomorphological and pathobiochemical findings, a survey of the literature on prophylaxis of occlusive arterial diseases is presented and the difference between anticoagulants and aggregation inhibitors is pointed out.

摘要

动脉血栓形成会导致重要功能紊乱

心肌梗死、缺血性脑梗死、外周血流障碍、肾硬化。血栓形成的预防仍是一个未解决的问题,因为至少在西方国家,由血栓形成引起的疾病仍然是首要死因。在描述了病理形态学和病理生物化学发现之后,本文对闭塞性动脉疾病预防方面的文献进行了综述,并指出了抗凝剂和聚集抑制剂之间的差异。

相似文献

1
Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?抗血小板药物还是双香豆素:哪种是闭塞性动脉疾病最有效的预防措施?
Int Angiol. 1986 Jul-Sep;5(3):169-80.
2
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].[颅外血管狭窄和闭塞的抗凝及血小板聚集抑制剂治疗]
Internist (Berl). 1979 Nov;20(11):539-46.
3
Antiplatelet agents: rationale and results.
Clin Haematol. 1983 Feb;12(1):311-54.
4
[Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].[使用抗凝剂、溶栓剂、血小板聚集抑制剂和β受体阻滞剂治疗心肌梗死]
Z Arztl Fortbild (Jena). 1984;78(5):167-71.
5
[Platelet antiaggregants in the treatment of arterial thrombosis].
Minerva Cardioangiol. 1991 Oct;39(10):375-89.
6
Myocardial infarction.
Clin Haematol. 1981 Jun;10(2):521-41.
7
Antiplatelet drugs in the management of patients with thrombotic disorders.
Semin Thromb Hemost. 1986 Apr;12(2):134-55. doi: 10.1055/s-2007-1003545.
8
[Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
Fortschr Med. 1982 May 13;100(18):825-30.
9
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Prog Clin Biol Res. 1982;89:31-62.
10
The use of antithrombotic drugs in artery disease.抗血栓药物在动脉疾病中的应用。
Clin Haematol. 1986 May;15(2):509-59.